معرفی
Kevin Talbot serves as Professor of Motor Neuron Biology and Head of the Nuffield Department of Clinical Neuroscience at the University of Oxford within the Medical Sciences Division. He founded the Oxford MND clinic at John Radcliffe Hospital, establishing a multidisciplinary clinical service for motor neuron disease patients across Southern England and leading the Oxford Motor Neuron Disease Centre.
His educational credentials include:
- MB BS from University of London (1990, with Distinction)
- DPhil from University of Oxford (1998)
- FRCP from Royal College of Physicians, London (2006)
Professor Talbot's research centers on identifying therapeutic targets for motor neuron diseases, particularly ALS. His laboratory utilizes patient-derived induced pluripotent stem cells to model motor neuron degeneration caused by genetic mutations such as TDP-43 and C9orf72. This approach integrates molecular neuroscience with clinical neurology to elucidate disease mechanisms and discover druggable pathways, operating within Oxford's collaborative neurodegenerative disease research ecosystem.
His 2025 publications reveal a strategic focus on translational ALS research, spanning genetic risk assessment (C9orf72/UNC13A), clinical progression modeling (weight loss prediction), biomarker discovery (TDP-43 vesicles), and neurophysiological monitoring (gamma oscillations). This portfolio demonstrates a cohesive effort to bridge molecular pathology with clinical applications through diverse methodological approaches.
His scientific recognition includes:
- MRC Clinician Scientist Fellowship (2001-2006)
- FRCP designation (2006)
Current research funding demonstrates sustained institutional confidence:
- Motor Neuron Disease Association (2001-2026)
- MND Scotland (2023-2026)
- My Name'5 Doddie Foundation (2019-2026)
- Alan Davidson Foundation (2022-2025)
- NIHR (2022-2027)
He directs the Oxford Motor Neuron Disease Centre while maintaining active membership in the UK MND Research Institute, fostering national and international collaborations that integrate clinical service with cutting-edge laboratory research in neurodegenerative diseases.
